Benzimidazole quinolinones and uses thereof

Details for Australian Patent Application No. 2003288899 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Heise, Carla C.; Jansen, Johanna M.; Silver, Joel B.; Wayman, Kelly; Ramurthy, Savithri; Ng, Simon; Jazan, Elisa; Barsanti, Paul A.; Wagman, Allan; McBride, Christopher; Pfister, Keith; McCrea, William R.; Wiesmann, Marion; Bussiere, Dirksen; Machajewski, Timothy D.; Pecchi, Sabina; Shafer, Cynthia M.; Harrison, Stephen D.; Ni, Zhi-Jie; Renhowe, Paul A.

Agent FB Rice

Pub. Number AU-B-2003288899

PCT Number PCT/US2003/0259

PCT Pub. Number WO2004/018419

Priority 60/428,210 21.11.02 US; 60/426,226 13.11.02 US; 60/460,328 03.04.03 US; 60/484,048 01.07.03 US; 60/460,327 03.04.03 US; 60/426,282 13.11.02 US; 60/426,107 13.11.02 US; 60/478,916 16.06.03 US; 60/405,729 23.08.02 US; 60/460,493 03.04.03 US

Filing date 19 August 2003

Wipo publication date 11 March 2004

Acceptance publication date 3 September 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 453/06 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/428,210 21.11.02 US; 60/426,226 13.11.02 US; 60/460,328 03.04.03 US; 60/484,048 01.07.03 US; 60/460,327 03.04.03 US; 60/426,282 13.11.02 US; 60/426,107 13.11.02 US; 60/478,916 16.06.03 US; 60/405,729 23.08.02 US; 60/460,493 03.04.03 US

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003288899

7 May 2009 Assignment before Grant

  Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc. 2004

3 September 2009 Application Accepted

  Published as AU-B-2003288899

5 November 2009 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003288900-LIGHT EMITTING DIODE, SUPPORT AND METHOD OF MANUFACTURE

2003288898-ANTISENSE MODULATION OF ENDOTHELIAL SPECIFIC MOLECULE 1 EXPRESSION